| Aripiprazole |
20150226 |
Explemed Rapid, Orodispersible tablet, 15, mg, Pack: 28 |
EGIS Pharmaceuticals PLC, Унгария |
EGIS Pharmaceuticals PLC, H-1165 Budapest, Bökényföldi út 118-120, Унгария |
58.71 |
11.74 |
70.45 |
4% |
2.35 |
61.06 |
12.21 |
73.27 |
16% |
9.39 |
70.45 |
14.09 |
84.54 |
|
НСР-7031/25.08.2015; НСР-10851/10.11.2016; НСР-15167/02.03.2018 |
17.03.2018 |
02.04.2018 |
Активен |
4066 |
| Aripiprazole |
20150226 |
Explemed Rapid, Orodispersible tablet, 15, mg, Pack: 28 |
EGIS Pharmaceuticals PLC, Унгария |
EGIS Pharmaceuticals PLC, H-1165 Budapest, Bökényföldi út 118-120, Унгария |
82.81 |
16.56 |
99.37 |
4% |
3.31 |
86.12 |
17.22 |
103.34 |
16% |
13.25 |
99.37 |
19.87 |
119.24 |
|
НСР-7031/25.08.2015; НСР-10851/10.11.2016 |
26.11.2016 |
02.12.2016 |
Неактивен |
4066 |
| Aripiprazole |
20150226 |
Explemed Rapid, Orodispersible tablet, 15, mg, Pack: 28 |
EGIS Pharmaceuticals PLC, Унгария |
EGIS Pharmaceuticals PLC, H-1165 Budapest, Bökényföldi út 118-120, Унгария |
84.75 |
16.95 |
101.7 |
4% |
3.39 |
88.14 |
17.63 |
105.77 |
16% |
13.56 |
101.7 |
20.34 |
122.04 |
|
НСР-7031/25.08.2015 |
09.09.2015 |
09.09.2015 |
Неактивен |
4066 |
| Interferon beta-1b |
ЕU/1/08/454/008 |
Extavia, Powder and solvent for solution for injection, 9.6, MIU, Pack: 15 |
Novartis Europharm Limited, Ирландия |
Novartis Pharma GmbH, Germany |
907.19 |
181.44 |
1088.63 |
4% |
10 |
917.19 |
183.44 |
1100.63 |
16% |
25 |
942.19 |
188.44 |
1130.63 |
Промяна на обстоятелствата НСР-16305/27.07.2018. |
НСР-7473/12.11.2015; НСР-14793/10.01.2018 |
25.01.2018 |
02.09.2018 |
Активен |
3155 |
| Interferon beta-1b |
ЕU/1/08/454/002 |
Extavia, Powder and solvent for solution for injection, 9.6, MIU, Pack: 15 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH, Germany |
907.19 |
181.44 |
1088.63 |
4% |
10 |
917.19 |
183.44 |
1100.63 |
16% |
25 |
942.19 |
188.44 |
1130.63 |
|
НСР-7473/12.11.2015; НСР-14793/10.01.2018 |
25.01.2018 |
02.02.2018 |
Неактивен |
3155 |
| Interferon beta-1b |
ЕU/1/08/454/002 |
Extavia, Powder and solvent for solution for injection, 9.6, MIU, Pack: 15 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH, Germany |
907.19 |
181.44 |
1088.63 |
4% |
10 |
917.19 |
183.44 |
1100.63 |
16% |
25 |
942.19 |
188.44 |
1130.63 |
|
НСР-7473/12.11.2015; НСР-14793/10.01.2018 |
25.01.2018 |
02.02.2018 |
Неактивен |
3155 |
| Interferon beta-1b |
ЕU/1/08/454/002 |
Extavia, Powder and solvent for solution for injection, 9.6, MIU, Pack: 15 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH, Germany |
981.81 |
196.36 |
1178.17 |
4% |
10 |
991.81 |
198.36 |
1190.17 |
16% |
25 |
1016.81 |
203.36 |
1220.17 |
|
НСР-7473/12.11.2015 |
27.11.2015 |
27.11.2015 |
Неактивен |
3155 |
| Interferon beta-1b |
ЕU/1/08/454/002 |
Extavia, Powder and solvent for solution for injection, 9.6, MIU, Pack: 15 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH, Germany |
1027.26 |
205.45 |
1232.71 |
4% |
10 |
1037.26 |
207.45 |
1244.71 |
16% |
25 |
1062.26 |
212.45 |
1274.71 |
|
НСР-4537/22.08.2014 |
08.09.2014 |
08.09.2014 |
Неактивен |
3155 |
| Interferon beta-1b |
ЕU/1/08/454/002 |
Extavia, Powder and solvent for solution for injection, 9.6, MIU, Pack: 15 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH, Germany |
1257.27 |
251.45 |
1508.72 |
4% |
10 |
1267.27 |
253.45 |
1520.72 |
16% |
25 |
1292.27 |
258.45 |
1550.72 |
промяна на обстоятелства НСР-4521/22.08.2014 ( в сила от 08.09.2014) |
НСР-1733/21.11.2013 |
09.12.2013 |
09.12.2013 |
Неактивен |
3155 |
| Interferon beta-1b |
ЕU/1/08/454/002 |
Extavia, Powder and solvent for solution for injection, 9.6, MIU, Pack: 15 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharmaceuticals UK Limited, Обединеното кралство |
1259.53 |
251.91 |
1511.44 |
4% |
10 |
1269.53 |
253.91 |
1523.44 |
16% |
25 |
1294.53 |
258.91 |
1553.44 |
|
КЦРР-2188/06.02.2013 г |
25.02.2013 |
25.02.2013 |
Неактивен |
3155 |
| Interferon beta-1b |
ЕU/1/08/454/002 |
Extavia, Powder and solvent for solution for injection, 9.6, MIU, Pack: 15 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharmaceuticals UK Limited, Обединеното кралство |
1737.21 |
347.44 |
2084.65 |
4% |
10 |
1747.21 |
349.44 |
2096.65 |
16% |
25 |
1772.21 |
354.44 |
2126.65 |
|
КЦ-259/20.10.2008 |
08.11.2008 |
08.11.2008 |
Неактивен |
3155 |
| Isotonic Solutions |
20030514 |
EXTRANEAL, Solution for peritoneal dialysis, Icodextrin 75 g/l; Sodium chloride 5.4 g/l; Calcium chloride 0.257 g/l, Magnesium chloride 0.051 g/l; Sodium lactate solution 4.5 g/l - 2000 ml, -, Pack: 1 |
Бакстер България ЕООД, България |
Baxter Healthcare S.A. Moneen Road, Castlebar, County Mayo, Ирландия; Baxter Healthcare Ltd., Caxton Way, Thetford, Norfolk IP24 3SE, UK |
13.46 |
2.69 |
16.15 |
6% |
0.81 |
14.27 |
2.85 |
17.12 |
18% |
2.42 |
16.69 |
3.34 |
20.03 |
промяна в обстоятелства НСР-5173/27.11.2014;промяна в обстоятелства НСР-12919/08.06.2017 |
КЦ-1706/09.09.2010 |
24.09.2010 |
02.07.2017 |
Активен |
957 |
| Isotonic Solutions |
II-9718/31.05.2010 |
EXTRANEAL, Solution for peritoneal dialysis, Icodextrin 75 g/l; Sodium chloride 5.4 g/l; Calcium chloride 0.257 g/l, Magnesium chloride 0.051 g/l; Sodium lactate solution 4.5 g/l - 2000 ml, ml, Pack: 1 |
Бакстер България ЕООД, България |
Baxter Healthcare S.A. Moneen Road, Castlebar, County Mayo, Ирландия; Baxter Healthcare Ltd., Caxton Way, Thetford, Norfolk IP24 3SE, UK |
13.46 |
2.69 |
16.15 |
6% |
0.81 |
14.27 |
2.85 |
17.12 |
18% |
2.42 |
16.69 |
3.34 |
20.03 |
промяна в обстоятелства НСР-5173/27.11.2014 |
КЦ-1706/09.09.2010 |
24.09.2010 |
24.09.2010 |
Неактивен |
957 |
| Isotonic Solutions |
II-9718/31.05.2010 |
EXTRANEAL, Solution for peritoneal dialysis, Icodextrin 75 g/l; Sodium chloride 5.4 g/l; Calcium chloride 0.257 g/l, Magnesium chloride 0.051 g/l; Sodium lactate solution 4.5 g/l - 2000 ml, g, Pack: 1 |
Бакстер България ЕООД, България |
Baxter Healthcare S.A. Moneen Road, Castlebar, County Mayo, Ирландия; Baxter Healthcare Ltd., Caxton Way, Thetford, Norfolk IP24 3SE, UK |
13.46 |
2.69 |
16.15 |
6% |
0.81 |
14.27 |
2.85 |
17.12 |
18% |
2.42 |
16.69 |
3.34 |
20.03 |
промяна в обстоятелства НСР-5173/27.11.2014 |
КЦ-1706/09.09.2010 |
24.09.2010 |
24.09.2010 |
Неактивен |
957 |
| Dasabuvir |
EU/1/14/983/001 |
Exviera, Film coated tablet, 250, mg, Pack: 56 |
AbbVie Deutschland GmbH & Co. KG, Германия |
AbbVie Deutschland GmbH & Co. KG, Knollstrasse 67061 Ludwigshafen, Германия |
1444.17 |
288.83 |
1733 |
4% |
10 |
1454.17 |
290.83 |
1745 |
16% |
25 |
1479.17 |
295.83 |
1775 |
Промяна на обстоятелствата НСР-16391/02.08.2018 |
НСР-7450/10.11.2015. (допуска се предварително изпълнение); НСР-9629/23.06.2016; НСР-14089/06.10.2017; НСР-17549/13.12.2018 предварително изпълнение |
13.12.2018 |
02.01.2019 |
Активен |
4092 |
| Dasabuvir |
EU/1/14/983/001 |
Exviera, Film coated tablet, 250, mg, Pack: 56 |
AbbVie Deutschland GmbH & Co. KG, Германия |
AbbVie Deutschland GmbH & Co. KG, Knollstrasse 67061 Ludwigshafen, Германия |
1498.2 |
299.64 |
1797.84 |
4% |
10 |
1508.2 |
301.64 |
1809.84 |
16% |
25 |
1533.2 |
306.64 |
1839.84 |
Промяна на обстоятелствата НСР-16391/02.08.2018 |
НСР-7450/10.11.2015. (допуска се предварително изпълнение); НСР-9629/23.06.2016; НСР-14089/06.10.2017 |
21.10.2017 |
02.09.2018 |
Неактивен |
4092 |
| Dasabuvir |
EU/1/14/983/001 |
Exviera, Film coated tablet, 250, mg, Pack: 56 |
AbbVie Ltd, Обединено Кралство |
AbbVie Deutschland GmbH & Co. KG, Knollstrasse 67061 Ludwigshafen, Германия |
1498.2 |
299.64 |
1797.84 |
4% |
10 |
1508.2 |
301.64 |
1809.84 |
16% |
25 |
1533.2 |
306.64 |
1839.84 |
|
НСР-7450/10.11.2015. (допуска се предварително изпълнение); НСР-9629/23.06.2016; НСР-14089/06.10.2017 |
21.10.2017 |
02.11.2017 |
Неактивен |
4092 |
| Dasabuvir |
EU/1/14/983/001 |
Exviera, Film coated tablet, 250, mg, Pack: 56 |
AbbVie Ltd, Обединено Кралство |
AbbVie Deutschland GmbH & Co. KG, Knollstrasse 67061 Ludwigshafen, Германия |
2039.23 |
407.85 |
2447.08 |
4% |
10 |
2049.23 |
409.85 |
2459.08 |
16% |
25 |
2074.23 |
414.85 |
2489.08 |
|
НСР-7450/10.11.2015. (допуска се предварително изпълнение); НСР-9629/23.06.2016 |
02.08.2016 |
02.08.2016 |
Неактивен |
4092 |
| Dasabuvir |
EU/1/14/983/001 |
Exviera, Film coated tablet, 250, mg, Pack: 56 |
AbbVie Ltd, Обединено Кралство |
AbbVie Deutschland GmbH & Co. KG, Knollstrasse 67061 Ludwigshafen, Германия |
2188.12 |
437.62 |
2625.74 |
4% |
10 |
2198.12 |
439.62 |
2637.74 |
16% |
25 |
2223.12 |
444.62 |
2667.74 |
|
НСР-7450/10.11.2015. (допуска се предварително изпълнение) |
10.11.2015 |
10.11.2015 |
Неактивен |
4092 |
| Aflibercept |
EU/1/12/797/002 |
Eylea, Solution for injection, 40 mg/ml - 100 µl, mg, Pack: 1 vial |
Bayer AG, Германия |
Bayer AG, Германия |
1163.17 |
232.63 |
1395.8 |
4% |
10 |
1173.17 |
234.63 |
1407.8 |
16% |
25 |
1198.17 |
239.63 |
1437.8 |
промяна на обстоятелства НСР-9687/30.06.2016; НСР-14210/19.10.2017 |
НСР-7570/26.11.2015.; НСР-11488/19.01.2017; НСР-15426/19.04.2018 |
04.05.2018 |
02.06.2018 |
Активен |
4126 |
| Aflibercept |
EU/1/12/797/002 |
Eylea, Solution for injection, 40 mg/ml - 100µl, mg, Pack: 1 vial |
Bayer AG, Германия |
Bayer AG, Германия |
1163.17 |
232.63 |
1395.8 |
4% |
10 |
1173.17 |
234.63 |
1407.8 |
16% |
25 |
1198.17 |
239.63 |
1437.8 |
промяна на обстоятелства НСР-9687/30.06.2016; НСР-14210/19.10.2017 |
НСР-7570/26.11.2015.; НСР-11488/19.01.2017; НСР-15426/19.04.2018 |
04.05.2018 |
02.06.2018 |
Неактивен |
4126 |
| Aflibercept |
EU/1/12/797/002 |
Eylea, Solution for injection, 40 mg/ml - 100µl, mg, Pack: 1 vial |
Bayer AG, Германия |
Bayer AG, Германия |
1163.21 |
232.64 |
1395.85 |
4% |
10 |
1173.21 |
234.64 |
1407.85 |
16% |
25 |
1198.21 |
239.64 |
1437.85 |
промяна на обстоятелства НСР-9687/30.06.2016; НСР-14210/19.10.2017 |
НСР-7570/26.11.2015.; НСР-11488/19.01.2017 |
03.02.2017 |
02.12.2017 |
Неактивен |
4126 |
| Aflibercept |
EU/1/12/797/002 |
Eylea, Solution for injection, 40 mg/ml - 100µl, mg, Pack: 1 vial |
Bayer AG, Германия |
Bayer AG, Германия |
1163.21 |
232.64 |
1395.85 |
4% |
10 |
1173.21 |
234.64 |
1407.85 |
16% |
25 |
1198.21 |
239.64 |
1437.85 |
промяна на обстоятелства НСР-9687/30.06.2016; НСР-14210/19.10.2017 |
НСР-7570/26.11.2015.; НСР-11488/19.01.2017 |
03.02.2017 |
02.12.2017 |
Неактивен |
4126 |
| Aflibercept |
EU/1/12/797/002 |
Eylea, Solution for injection, 40 mg/ml - 100µl, mg, Pack: 1 vial |
Bayer Pharma AG, Германия |
Bayer Pharma AG, Müllerstraße 178, D-13353 Berlin, Германия |
1163.21 |
232.64 |
1395.85 |
4% |
10 |
1173.21 |
234.64 |
1407.85 |
16% |
25 |
1198.21 |
239.64 |
1437.85 |
промяна на обстоятелства НСР-9687/30.06.2016 |
НСР-7570/26.11.2015.; НСР-11488/19.01.2017 |
02.03.2017 |
02.03.2017 |
Неактивен |
4126 |
| Aflibercept |
EU/1/12/797/002 |
Eylea, Solution for injection, 40 mg/ml - 100µl, mg, Pack: 1 vial |
Bayer Pharma AG, Германия |
Bayer Pharma AG, Müllerstraße 178, D-13353 Berlin, Германия |
1250.75 |
250.15 |
1500.9 |
4% |
10 |
1260.75 |
252.15 |
1512.9 |
16% |
25 |
1285.75 |
257.15 |
1542.9 |
промяна на обстоятелства НСР-9687/30.06.2016 |
НСР-7570/26.11.2015. |
12.12.2015 |
12.12.2015 |
Неактивен |
4126 |